The law and ethics of access to medicines in developing countries

&
In Yann Joly & Bartha Maria Knoppers (eds.), Routledge Handbook of Medical Law and Ethics. New York, NY: Routledge (2014)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,610

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.
GlaxoSmithKline and Access to Essential Medicines (B).N. Craig Smith & Anne Duncan - 2005 - Journal of Business Ethics Education 2 (1):123-132.
GlaxoSmithKline and Access to Essential Medicines (B).N. Craig Smith & Anne Duncan - 2005 - Journal of Business Ethics Education 2 (1):123-132.
Narrowing the gap: access to HIV treatments in developing countries. A pharmaceutical company's perspective.J. Cochrane - 2000 - Journal of Medical Ethics 26 (1):47-50.
Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects.Robert C. Bird - 2009 - Journal of Law, Medicine and Ethics 37 (2):209-221.
Access to Medicines in Developing Countries: Ethical Demands and Moral Economy.Marilena Correa Maurice Cassier - 2014 - Developing World Bioethics 14 (2):ii-viii.
Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects.Robert C. Bird - 2009 - Journal of Law, Medicine and Ethics 37 (2):209-221.
Rationing the access to high cost medicines in developing countries.Debora Diniz - 2009 - Developing World Bioethics 9 (2):ii-iii.
Access to Medicines in Developing Countries: Ethical Demands and Moral Economy.Maurice Cassier & Marilena Correa - 2014 - Developing World Bioethics 14 (2):ii-viii.
Law, Politics, and Access to Essential Medicines in Developing Countries.Heinz Klug - 2008 - Politics and Society 36 (2):207-245.
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.
Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health.Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander - 2012 - Journal of Law, Medicine and Ethics 40 (2):234-250.
Basic Survival Needs and Access to Medicines – Coming to Grips with TRIPS: Conversion + Calculation.Rudolf V. Van Puymbroeck - 2010 - Journal of Law, Medicine and Ethics 38 (3):520-549.
Global health impact: A basis for labeling and licensing campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Supply of medicines: paternalism, autonomy and reality.D. Prayle & M. Brazier - 1998 - Journal of Medical Ethics 24 (2):93-98.

Analytics

Added to PP
2023-08-28

Downloads
0

6 months
0

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references